Nutex Health Inc.
Organization details
- Legal name
- Nutex Health Inc.
- Former names
- Clinigence Holdings, Inc. iGambit, Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Industrials
- SIC code
- 7389 — Services-Business Services, NEC
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Houston
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NUTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001479681
- EIN
- 11-3363609
Board of directors
-
Cheryl Yvonne Grenas · DirectorSince 2023
-
Danniel Stites · DirectorSince 2023
-
Frank E. Jaumot · DirectorSince 2025
-
John J. Waters · DirectorSince 2023
-
Kelvin Spears · DirectorSince 2024
-
Michael Lee Reed · DirectorSince 2023
-
Mitchell Creem · DirectorSince 2023
-
Scott J. Saunders · DirectorSince 2024
-
Thomas T. Vo · Director · Chief Executive OfficerSince 2023
-
Warren Hosseinion · Director · PresidentSince 2023
Chief executives
Director election results
Annual meeting of April 23, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
95.1%
-
95.5%
-
95.8%
-
96.6%
-
96.7%
-
96.7%
-
99.3%
Board connections
2 of this board's directors also sit on 4 other boards.
- via Warren Hosseinion
- via Warren Hosseinion
- via Mitchell Creem
- via Warren Hosseinion
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $148,237
- 5 purchases by 5 insiders
- Sold, last 12 months
- $43,493
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 18, 2026 | Scott J. Saunders Director | Open-market sale | −203 | $214.25 | $43,493 |
| Jul 31, 2026 | Cheryl Yvonne Grenas Director | Option exercise | +603 | — | — |
| Jul 31, 2026 | Frank E. Jaumot Director | Option exercise | +603 | — | — |
| Jul 31, 2026 | Michael Lee Reed Director | Option exercise | +603 | — | — |
| Jul 31, 2026 | Scott J. Saunders Director | Option exercise | +603 | — | — |
| Jun 4, 2026 | Kelvin Spears Director | Other | +2,519 | — | — |
| May 28, 2026 | Thomas T. Vo Director, Officer (Chief Executive Officer) | Other | +75,747 | — | — |
| Apr 9, 2026 | Thomas T. Vo Director, Officer (Chief Executive Officer) | Other | +184,071 | — | — |
| Mar 20, 2026 | Frank E. Jaumot Director | Open-market purchase | +150 | $93.56 | $14,034 |
| Mar 19, 2026 | Warren Hosseinion Director, Officer (President) | Open-market purchase | +252 | $94.07 | $23,706 |
| Mar 17, 2026 | Kelvin Spears Director | Open-market purchase | +10 | $94.46 | $945 |
| Mar 13, 2026 | Montgomery Pamela W. Officer (Chief Legal Officer-Healthcare) | Open-market purchase | +79 | $88.87 | $7,021 |
| Mar 10, 2026 | Luqman Elisa V Officer (Chief Legal Officer - SEC) | Option exercise | +2,084 | — | — |
| Mar 10, 2026 | Montgomery Pamela W. Officer (Chief Legal Officer-Healthcare) | Option exercise | +2,084 | — | — |
| Mar 10, 2026 | Kelvin Spears Director | Option exercise | +183 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Nutex Health Inc.
Who is the CEO of Nutex Health Inc.?
Thomas T. Vo is Nutex Health Inc.'s Chief Executive Officer.
How many directors are on Nutex Health Inc.'s board?
Nutex Health Inc.'s board has 10 directors: Cheryl Yvonne Grenas, Danniel Stites, Frank E. Jaumot, John J. Waters, Kelvin Spears, Michael Lee Reed, Mitchell Creem, Scott J. Saunders, Thomas T. Vo and Warren Hosseinion.
Are Nutex Health Inc. insiders buying or selling shares?
Over the last 12 months, Nutex Health Inc. insiders bought $148,237 of shares in 5 purchases and sold $43,493 of shares in 1 sale on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="nutex-health-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.